|
?:authorAffiliation
|
-
[\'Department of Bioengineering and Therapeutic Sciences and Programs in Biological Sciences and Human Genetics, University of California, San Francisco, San Francisco, CA, 94158, USA. Jeffrey.kim@ucsf.edu.\', \'Graduate Program of Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, 94158, USA. Jeffrey.kim@ucsf.edu.\', \'Department of Bioengineering and Therapeutic Sciences and Programs in Biological Sciences and Human Genetics, University of California, San Francisco, San Francisco, CA, 94158, USA.\', \'Graduate Program of Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, 94158, USA.\', \'Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, 94158, USA.\', \'Department of Bioengineering and Therapeutic Sciences and Programs in Biological Sciences and Human Genetics, University of California, San Francisco, San Francisco, CA, 94158, USA. Su.guo@ucsf.edu.\', \'Graduate Program of Pharmaceutical Sciences and Pharmacogenomics, University of California, San Francisco, San Francisco, CA, 94158, USA. Su.guo@ucsf.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}